Author

Fred Aswad

Primary ORCID profile (0000-0001-9062-3735 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Fred AswadiD1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

James Joseph· 1 shared Jason StumpffiD· 1 shared Katelyn A. Queen· 1 shared Katherine Schutt· 1 shared Kira Fisher· 1 shared Olivia Budington· 1 shared Wei Liu· 1 shared Weifeng Mao· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

James Joseph

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 16, 2023

Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells

Katherine Schutt, Katelyn A. Queen, Kira Fisher…·Jason Stumpff

This study identifies the KIF18A alpha-4 helix as a therapeutic target, showing that mutations or inhibitors targeting this region disrupt proliferation of chromosomally unstable tumor cells.

DOI 10.1101/2023.10.16.562576

humanproteomics

𝕏 PostBluesky